AbbVie Inc. Quarterly Depreciation in USD from Q1 2012 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
AbbVie Inc. quarterly/annual Depreciation history and growth rate from Q1 2012 to Q4 2024.
  • AbbVie Inc. Depreciation for the quarter ending December 31, 2024 was $206M, a 10.2% increase year-over-year.
  • AbbVie Inc. Depreciation for the twelve months ending December 31, 2024 was $764M, a 1.6% increase year-over-year.
  • AbbVie Inc. annual Depreciation for 2024 was $764M, a 1.6% increase from 2023.
  • AbbVie Inc. annual Depreciation for 2023 was $752M, a 3.34% decline from 2022.
  • AbbVie Inc. annual Depreciation for 2022 was $778M, a 3.11% decline from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $764M $206M +$19M +10.2% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-14
Q3 2024 $745M $191M -$5M -2.55% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $750M $184M -$6M -3.16% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $756M $183M +$4M +2.24% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $752M $187M -$9M -4.59% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-14
Q3 2023 $761M $196M +$15M +8.29% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $746M $190M -$13M -6.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $759M $179M -$19M -9.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $778M $196M +$23M +13.3% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-14
Q3 2022 $755M $181M -$42M -18.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $797M $203M +$2M +1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $795M $198M -$8M -3.88% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $803M $173M -$54M -23.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $857M $223M +$48M +27.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $809M $201M +$52M +34.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $757M $206M +$91M +79.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $666M $227M +$109M +92.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q3 2020 $557M $175M +$61M +53.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $496M $149M +$35M +30.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-02
Q1 2020 $461M $115M -$3M -2.54% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $464M $118M -$4M -3.28% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-18
Q3 2019 $468M $114M -$1M -0.87% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $469M $114M -$5M -4.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $474M $118M +$3M +2.61% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $471M $122M +$21M +20.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $450M $115M +$4M +3.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $446M $119M +$9M +8.18% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $437M $115M +$12M +11.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $425M $101M -$17M -14.4% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $442M $111M +$15M +15.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $427M $110M +$2M +1.85% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $425M $103M $0 0% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $425M $118M -$3M -2.48% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $428M $96M -$6M -5.88% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $434M $108M +$4M +3.85% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $430M $103M +$13M +14.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $417M $121M +$24M +24.7% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-16
Q3 2015 $393M $102M +$8M +8.51% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $385M $104M +$1M +0.97% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $384M $90M +$1M +1.12% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $383M $97M -$2M -2.02% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-17
Q3 2014 $385M $94M -$3M -3.09% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $388M $103M +$3M +3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $385M $89M -$3M -3.26% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $388M $99M -$74M -42.8% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 $462M $97M +$4M +4.3% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $458M $100M -$19M -16% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $477M $92M -$48M -34.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 $525M $173M Oct 1, 2012 Dec 31, 2012 10-K 2015-02-20
Q3 2012 $93M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $119M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $140M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.